{"id":"https://openalex.org/W1974054076","doi":"https://doi.org/10.3892/ijmm.13.4.545","title":"A novel antimetabolite, TAS-102 retains its effect on FU-related resistant cancer cells","display_name":"A novel antimetabolite, TAS-102 retains its effect on FU-related resistant cancer cells","alternate_titles":[],"publication_year":2004,"publication_date":"2004-04-01","ids":{"openalex":"https://openalex.org/W1974054076","doi":"https://doi.org/10.3892/ijmm.13.4.545","mag":"1974054076","pmid":"https://pubmed.ncbi.nlm.nih.gov/15010854"},"language":"en","primary_location":{"id":"doi:10.3892/ijmm.13.4.545","doi":"https://doi.org/10.3892/ijmm.13.4.545","is_oa":false,"landing_page_url":"https://doi.org/10.3892/ijmm.13.4.545","pdf_url":null,"source":{"id":"https://openalex.org/S192722082","display_name":"International Journal of Molecular Medicine","issn_l":"1107-3756","issn":["1107-3756","1791-244X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","medline","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320412","host_organization_name":"Spandidos Publishing","host_organization_lineage":["https://openalex.org/P4310320412"],"host_organization_lineage_names":["Spandidos Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Molecular Medicine","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1974054076"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5090059332","display_name":"Tomohiro Emura","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210120269","display_name":"Taiho Pharmaceutical (Japan)","ror":"https://ror.org/02v50dx14","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210120269"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Tomohiro Emura","raw_affiliation_strings":["Cancer Research Laboratory, Hanno Research Center, Taiho Pharmaceutical Co., Ltd. 1-27, Misugidai, Hanno-city, Saitama 357-8527, Japan. t-emura@taiho.co.jp"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Research Laboratory, Hanno Research Center, Taiho Pharmaceutical Co., Ltd. 1-27, Misugidai, Hanno-city, Saitama 357-8527, Japan. t-emura@taiho.co.jp","institution_ids":["https://openalex.org/I4210120269"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103227827","display_name":"Yuko Murakami","orcid":"https://orcid.org/0000-0003-2871-1499","observed_orcids":["https://orcid.org/0000-0003-2871-1499"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yuko Murakami","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108833734","display_name":"Fumio Nakagawa","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Fumio Nakagawa","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112318990","display_name":"Masakazu Fukushima","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Masakazu Fukushima","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5109179192","display_name":"Kenji Kitazato","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kenji Kitazato","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.2039,"has_fulltext":false,"cited_by_count":110,"citation_normalized_percentile":{"value":0.77612727,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"13","issue":"4","first_page":"545","last_page":"549"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.8051999807357788,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.8051999807357788,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.08820000290870667,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12827","display_name":"Biochemical and Molecular Research","score":0.050700001418590546,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/trifluridine-tipiracil","display_name":"trifluridine/tipiracil","score":1.0},{"id":"https://openalex.org/keywords/fluorodeoxyuridine","display_name":"fluorodeoxyuridine","score":0.5960000157356262},{"id":"https://openalex.org/keywords/5-fluorouracil-resistance","display_name":"5-fluorouracil resistance","score":0.9110000133514404},{"id":"https://openalex.org/keywords/thymidine-phosphorylase-inhibitor","display_name":"thymidine phosphorylase inhibitor","score":0.7879999876022339},{"id":"https://openalex.org/keywords/thymidylate-synthase-inhibition","display_name":"thymidylate synthase inhibition","score":0.8740000128746033},{"id":"https://openalex.org/keywords/colorectal-cancer","display_name":"colorectal cancer","score":0.8980000019073486},{"id":"https://openalex.org/keywords/liver-metastases","display_name":"liver metastasis","score":0.9940000176429749},{"id":"https://openalex.org/keywords/antiangiogenic-activity","display_name":"antiangiogenic activity","score":0.8240000009536743},{"id":"https://openalex.org/keywords/thymidine-phosphorylase","display_name":"thymidine phosphorylase","score":0.9580000042915344},{"id":"https://openalex.org/keywords/xenograft-models","display_name":"xenograft models","score":0.8190000057220459},{"id":"https://openalex.org/keywords/oral-anticancer-drugs","display_name":"oral anticancer drugs","score":0.7850000262260437}],"concepts":[{"id":"https://openalex.org/C2776735402","wikidata":"https://www.wikidata.org/wiki/Q22038268","display_name":"Thymidine phosphorylase","level":3,"score":0.8539472222328186},{"id":"https://openalex.org/C123321153","wikidata":"https://www.wikidata.org/wiki/Q22676802","display_name":"Thymidylate synthase","level":4,"score":0.6931359171867371},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.6662832498550415},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.659209132194519},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.603611946105957},{"id":"https://openalex.org/C2781018059","wikidata":"https://www.wikidata.org/wiki/Q207609","display_name":"Oncogene","level":4,"score":0.6000642776489258},{"id":"https://openalex.org/C2778397455","wikidata":"https://www.wikidata.org/wiki/Q50429865","display_name":"Antimetabolite","level":3,"score":0.5989629030227661},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5564652681350708},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5450184941291809},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.528983473777771},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.5194385051727295},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.510992169380188},{"id":"https://openalex.org/C2776231280","wikidata":"https://www.wikidata.org/wiki/Q623031","display_name":"Liver cancer","level":3,"score":0.4647046625614166},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.4365200102329254},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.43205684423446655},{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.4260011613368988},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.35183221101760864},{"id":"https://openalex.org/C2780456651","wikidata":"https://www.wikidata.org/wiki/Q238512","display_name":"Fluorouracil","level":3,"score":0.19319003820419312},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.18877190351486206},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000963","descriptor_name":"Antimetabolites","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004396","descriptor_name":"Coloring Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D005914","descriptor_name":"Globins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008099","descriptor_name":"Liver","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008113","descriptor_name":"Liver Neoplasms","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008807","descriptor_name":"Mice, Inbred BALB C","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008819","descriptor_name":"Mice, Nude","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008956","descriptor_name":"Models, Chemical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009362","descriptor_name":"Neoplasm Metastasis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009368","descriptor_name":"Neoplasm Transplantation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011759","descriptor_name":"Pyrrolidines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012680","descriptor_name":"Sensitivity and Specificity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013778","descriptor_name":"Tetrazolium Salts","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D013939","descriptor_name":"Thymidine Phosphorylase","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D013941","descriptor_name":"Thymine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014271","descriptor_name":"Trifluridine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D014271","descriptor_name":"Trifluridine","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D014498","descriptor_name":"Uracil","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D014498","descriptor_name":"Uracil","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D014498","descriptor_name":"Uracil","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D016133","descriptor_name":"Polymerase Chain Reaction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.3892/ijmm.13.4.545","doi":"https://doi.org/10.3892/ijmm.13.4.545","is_oa":false,"landing_page_url":"https://doi.org/10.3892/ijmm.13.4.545","pdf_url":null,"source":{"id":"https://openalex.org/S192722082","display_name":"International Journal of Molecular Medicine","issn_l":"1107-3756","issn":["1107-3756","1791-244X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","medline","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320412","host_organization_name":"Spandidos Publishing","host_organization_lineage":["https://openalex.org/P4310320412"],"host_organization_lineage_names":["Spandidos Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Molecular Medicine","raw_type":"journal-article"},{"id":"pmid:15010854","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15010854","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of molecular medicine","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320311653","display_name":"Taiho Pharmaceutical","ror":"https://ror.org/02v50dx14"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2025641756","https://openalex.org/W2005441587","https://openalex.org/W1895950452","https://openalex.org/W1889053010","https://openalex.org/W3134532853","https://openalex.org/W2094073768","https://openalex.org/W2189078621","https://openalex.org/W2202551455","https://openalex.org/W2331313649","https://openalex.org/W2117861430"],"abstract_inverted_index":{"TAS-102":[0,25,126,149,180,211,235],"is":[1,26,51,72,167,236],"a":[2,10,14,73,128,154,204,237],"new":[3],"oral":[4],"anti-tumor":[5,123,219],"drug":[6],"preparation,":[7],"composed":[8],"of":[9,17,42,57,66,125,148,157,164,185],"1:0.5":[11],"mixture":[12],"(on":[13],"molar":[15],"basis)":[16],"alpha,alpha,alpha-tri-fluorothymidine":[18],"(FTD)":[19],"and":[20,31,46,86,92,102,139,179,226,243],"thymidine":[21,209],"phosphorylase":[22],"inhibitor":[23],"(TPI).":[24],"currently":[27],"undergoing":[28],"clinical":[29,75,241],"trials,":[30],"has":[32],"been":[33],"demonstrated":[34],"to":[35,69,200,203,215,247],"have":[36,216],"at":[37],"least":[38],"2":[39],"mechanisms;":[40],"inhibition":[41,105],"thymidylate":[43],"synthase":[44],"(TS)":[45],"incorporation":[47],"into":[48],"DNA.":[49],"5-FU":[50,70,91,103],"widely":[52],"used":[53],"in":[54,84,87,107,127,153],"the":[55,61,78,116,122,146,183],"treatment":[56],"solid":[58],"tumor,":[59],"but":[60,222],"inherent":[62],"or":[63],"acquired":[64],"resistance":[65],"certain":[67],"tumors":[68],"therapy":[71],"major":[74],"problem.":[76],"In":[77],"present":[79],"study,":[80],"we":[81],"investigated":[82,121],"FTD":[83,101],"vitro":[85],"vivo":[88],"comparing":[89],"with":[90,169],"using":[93],"FU-resistant":[94,129,137],"cells.":[95],"There":[96],"was":[97,113,134,175,198],"no":[98],"relationship":[99],"between":[100,136],"growth":[104,195],"effect":[106],"vitro.":[108],"A":[109,188],"different":[110],"sensitivity":[111],"pattern":[112],"observed":[114,135],"by":[115,177],"log-mean":[117],"graph.":[118],"We":[119,143],"next":[120],"activity":[124,225],"xenograft":[130],"model.":[131],"Comparative":[132],"efficacy":[133],"cell":[138,194],"its":[140],"parent":[141],"cell.":[142],"also":[144,223],"studied":[145],"influence":[147],"on":[150],"liver":[151,162,186,229],"metastasis":[152,163],"mouse":[155],"model":[156],"human":[158],"colorectal":[159,165],"cancer,":[160],"because":[161],"cancer":[166,173],"associated":[168],"patient":[170],"survival.":[171],"Human":[172],"DNA":[174],"detected":[176],"PCR,":[178],"markedly":[181],"inhibited":[182],"number":[184],"metastasis.":[187,230],"novel":[189],"angiogenic":[190],"factor,":[191],"platelet-derived":[192],"endothelial":[193],"factor":[196],"(PD-ECGF),":[197],"shown":[199],"be":[201,213,245],"identical":[202],"previously":[205],"characterized":[206],"intracellular":[207],"enzyme,":[208],"phosphorylase,":[210],"can":[212,244],"expected":[214,246],"not":[217],"only":[218],"cytocidal":[220],"effects":[221],"antiangiogenesis":[224],"may":[227],"inhibit":[228],"Our":[231],"findings":[232],"suggested":[233],"that":[234],"promising":[238],"candidate":[239],"for":[240],"use":[242],"decrease":[248],"minimal":[249],"residual":[250],"disease.":[251]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1974054076","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":9},{"year":2020,"cited_by_count":9},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":9},{"year":2016,"cited_by_count":11},{"year":2015,"cited_by_count":12},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
